Stay updated on Venetoclax and Azacitidine in MDS/CMML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page
- Check2 days agoChange DetectedThe record history now includes a new site revision entry (v3.6.5) replacing the previous v3.6.4, indicating a small platform update to the page. This change does not affect study details or other content on the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.4, was added to the Study Record Versions list. The previous v3.6.3 entry appears superseded in the current view, reflecting an update to the record's metadata.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe study record history shows a new revision entry (v3.6.3) added to the timeline, replacing the prior version, indicating an update to the page's version metadata.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous revision v3.6.0 was removed from the list.SummaryDifference0.1%

- Check60 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The version history now shows a new revision tag v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.5%

- Check67 days agoChange DetectedThe study record versions now indicate termination with less than 75% participation and updated recruitment and study status sections, reflecting a major shift in the trial's lifecycle. The previous 'Active, not recruiting' status has been removed as part of this update.SummaryDifference0.8%

Stay in the know with updates to Venetoclax and Azacitidine in MDS/CMML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in MDS/CMML Clinical Trial page.